Increased 17β-hydroxysteroid dehydrogenase type 1 levels in primary cervical cancer

被引:7
|
作者
Tomaszewska, Agata [1 ,2 ]
Roszak, Andrzej [3 ,4 ]
Pawlik, Piotr [5 ]
Sajdak, Stefan [5 ]
Jagodzinski, Pawel Piotr [1 ]
机构
[1] Poznan Univ Med Sci, Dept Biochem & Mol Biol, PL-60781 Poznan, Poland
[2] Poznan Univ Med Sci, Ctr Orthodont Miniimplants, Chair & Clin Maxillofacial Orthoped & Orthodont, PL-60781 Poznan, Poland
[3] Poznan Univ Med Sci, Dept Electroradiol, PL-60781 Poznan, Poland
[4] Greater Poland Canc Ctr, Dept Radiotherapy & Gynecol Oncol, Poznan, Poland
[5] Poznan Univ Med Sci, Div Gynecol Surg, PL-60781 Poznan, Poland
关键词
HSD17B1; Cervical cancer; 17; beta-Estradiol; HUMAN-PAPILLOMAVIRUS TYPE-16; CELL-LINES; SQUAMOUS CARCINOGENESIS; ESTROGEN; EXPRESSION; ESTRADIOL; RISK; E6; 17-BETA-ESTRADIOL; DEHYDROGENASES;
D O I
10.1016/j.biopha.2015.04.018
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Infections with oncogenic human papillomavirus (HPV) strains are recognized as the major risk factor for developing malignant lesions in the uterine cervix. However, several findings have demonstrated cooperation between HPV infection and 17 beta-estradiol (E2) in cervical carcinogenesis. The 17 beta-hydroxysteroid dehydrogenase type 1 (HSD17B1) is the enzyme involved in the transformation of estrone (E1) into E2. In this study, we identified the HSD17B1 transcript and protein in HeLa, SiHa, Ca Ski and C-33A cervical cancer cells. These cells were able to convert E1 to E2 in a time-dependent manner. Moreover, we identified the HSD17B1 transcript and protein in primary cancerous tissues (n = 28) and in histologically unchanged tissues (n = 25). We did not observe significant differences (P = 0.33) between the HSD17B1 transcript levels in cancerous tissues and histologically unchanged tissues. However, we found an overrepresentation of the HSD17B1 protein in cancerous tissues compared with histologically unchanged tissues (P < 0.001). This overrepresentation of the HSD17B1 protein in primary cervical cancerous tissues may be responsible for the local conversion of E1 to E2. (C) 2015 Elsevier Masson SAS. All rights reserved.
引用
收藏
页码:179 / 183
页数:5
相关论文
共 50 条
  • [21] Evolutionary analysis of 11β-hydroxysteroid dehydrogenase-type 1, -type 2, -type 3 and 17β-hydroxysteroid dehydrogenase-type 2 in fish
    Baker, ME
    FEBS LETTERS, 2004, 574 (1-3): : 167 - 170
  • [22] 17β-hydroxysteroid dehydrogenase type 1 and 2 expression in the human fetus
    Takeyama, J
    Suzuki, T
    Hirasawa, G
    Muramatsu, Y
    Nagura, H
    Iinuma, K
    Nakamura, J
    Kimura, K
    Yoshihama, M
    Harada, N
    Andersson, S
    Sasano, H
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2000, 85 (01): : 410 - 416
  • [23] Expression and regulation of 17 beta-hydroxysteroid dehydrogenase type 1
    Peltoketo, H
    Isomaa, V
    Poutanen, M
    Vihko, R
    JOURNAL OF ENDOCRINOLOGY, 1996, 150 : S21 - S30
  • [24] Characterization of type 12 17β-hydroxysteroid dehydrogenase, an isoform of type 3 17β-hydroxysteroid dehydrogenase responsible for estradiol formation in women
    Luu-The, V
    Tremblay, P
    Labrie, F
    MOLECULAR ENDOCRINOLOGY, 2006, 20 (02) : 437 - 443
  • [25] Novel inhibitors of 17β-hydroxysteroid dehydrogenase type 1:: Templates for design
    Allan, Gillian M.
    Vicker, Nigel
    Lawrence, Harshani R.
    Tutill, Helena J.
    Day, Joanna M.
    Huchet, Marion
    Ferrandis, Eric
    Reed, Michael J.
    Purohit, Atul
    Potter, Barry V. L.
    BIOORGANIC & MEDICINAL CHEMISTRY, 2008, 16 (08) : 4438 - 4456
  • [26] Increased expression of type 2 3α-hydroxysteroid dehydrogenase/type 5 17β-hydroxysteroid dehydrogenase (AKR1C3) and its relationship with androgen receptor in prostate carcinoma
    Fung, KM
    Samara, ENS
    Wong, C
    Metwalli, A
    Krlin, R
    Bane, B
    Liu, CZ
    Yang, JT
    Pitha, JV
    Culkin, DJ
    Kropp, BP
    Penning, TM
    Lin, HK
    ENDOCRINE-RELATED CANCER, 2006, 13 (01) : 169 - 180
  • [27] The increased ratio of 11β-hydroxysteroid dehydrogenase type 1 versus 11β-hydroxysteroid dehydrogenase type 2 in chronic periodontitis irrespective of obesity
    Nakata, Takaya
    Fujita, Atsuko
    Umeda, Makoto
    Yoshida, Hiroaki
    Inami, Kaoru
    Masuzaki, Hiroaki
    Sawai, Hirofumi
    SPRINGERPLUS, 2016, 5 : 1 - 7
  • [28] Preclinical Assessment of 17β-Hydroxysteroid Dehydrogenase-1 in Endometrial Cancer
    Konings, G. F. J.
    Cornel, K. M. C.
    Xanthoulea, S.
    Delvoux, B.
    Saarinen, N.
    Kooreman, L.
    Koskimies, P.
    Krakstad, C.
    Fasmer, K. E.
    Haldorsen, I. S.
    Hakkinen, M. R.
    Auriola, S.
    Dubois, L.
    Lieuwes, N.
    Verhaegen, F.
    Schyns, L. E. J.
    Salvesen, H. B.
    Groot, A. J.
    Bongers, M. Y.
    Kruitwagen, R. F. P.
    Romano, A.
    JOURNAL OF PATHOLOGY, 2018, 246 : S18 - S18
  • [29] Levels of 17β-hydroxysteroid dehydrogenase type 10 in CSF are not a valuable biomarker for multiple sclerosis
    Kristofikova, Zdenka
    Ricny, Jan
    Kaping, Daniel
    Klaschka, Jan
    Kotoucova, Jolana
    Bartos, Ales
    BIOMARKERS IN MEDICINE, 2018, 12 (12) : 1331 - 1340
  • [30] 17β-hydroxysteroid dehydrogenase type 11 (Pan1b) expression in human prostate cancer
    Nakamura, Y.
    Suzuki, T.
    Arai, Y.
    Sasano, H.
    NEOPLASMA, 2009, 56 (04) : 317 - 320